Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Sofia Agelaki; Antonia Kalykaki; Harris Markomanolaki; Maria A. Papadaki; Galatea Kallergi; Dora Hatzidaki; Kostas Kalbakis; Dimitrios Mavroudis; Vassilis Georgoulias

doi:10.1371/journal.pone.0123683

Loading metrics

Open Access

Peer-reviewed

Research Article

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Sofia Agelaki ,

Contributed equally to this work with: Sofia Agelaki, Antonia Kalykaki

* E-mail: georgsec@med.uoc.gr

Affiliations Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece, Laboratory of Tumor Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece
⨯
Antonia Kalykaki ,

Contributed equally to this work with: Sofia Agelaki, Antonia Kalykaki

Affiliation Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece
⨯
Harris Markomanolaki,

Affiliation Laboratory of Tumor Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece
⨯
Maria A. Papadaki,

Affiliation Laboratory of Tumor Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece
⨯
Galatea Kallergi,

Affiliation Laboratory of Tumor Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece
⨯
Dora Hatzidaki,

Affiliation Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece
⨯
Kostas Kalbakis,

Affiliation Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece
⨯
Dimitrios Mavroudis,

Affiliations Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece, Laboratory of Tumor Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece
⨯
Vassilis Georgoulias

Affiliations Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece, Laboratory of Tumor Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece
⨯

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Sofia Agelaki,
Antonia Kalykaki,
Harris Markomanolaki,
Maria A. Papadaki,
Galatea Kallergi,
Dora Hatzidaki,
Kostas Kalbakis,
Dimitrios Mavroudis,
Vassilis Georgoulias

Published: June 17, 2015
https://doi.org/10.1371/journal.pone.0123683

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Hormonal therapy
Is the Subject Area "Hormonal therapy" applicable to this article?

Thanks for your feedback.
Immunofluorescence staining
Is the Subject Area "Immunofluorescence staining" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.